Ieq Capital LLC Buys 122,282 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Ieq Capital LLC increased its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 764.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 138,276 shares of the company’s stock after acquiring an additional 122,282 shares during the quarter. Ieq Capital LLC owned approximately 0.06% of Bath & Body Works worth $5,361,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of BBWI. Blue Trust Inc. lifted its holdings in Bath & Body Works by 54.0% during the third quarter. Blue Trust Inc. now owns 4,262 shares of the company’s stock worth $136,000 after acquiring an additional 1,495 shares during the period. Raymond James & Associates lifted its holdings in Bath & Body Works by 6.8% during the third quarter. Raymond James & Associates now owns 89,680 shares of the company’s stock worth $2,863,000 after acquiring an additional 5,706 shares during the period. Sequoia Financial Advisors LLC lifted its holdings in Bath & Body Works by 14.9% during the third quarter. Sequoia Financial Advisors LLC now owns 6,514 shares of the company’s stock worth $208,000 after acquiring an additional 847 shares during the period. Impact Partnership Wealth LLC bought a new stake in Bath & Body Works during the third quarter worth $365,000. Finally, Assenagon Asset Management S.A. lifted its holdings in Bath & Body Works by 723.4% during the third quarter. Assenagon Asset Management S.A. now owns 1,167,554 shares of the company’s stock worth $37,268,000 after acquiring an additional 1,025,757 shares during the period. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Stock Down 4.5 %

Bath & Body Works stock opened at $38.51 on Friday. Bath & Body Works, Inc. has a 52 week low of $26.20 and a 52 week high of $52.99. The business has a 50-day simple moving average of $37.70 and a 200 day simple moving average of $33.86. The stock has a market cap of $8.34 billion, a price-to-earnings ratio of 9.39, a PEG ratio of 0.95 and a beta of 1.83.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.58 billion. During the same period in the previous year, the business earned $0.48 earnings per share. The firm’s revenue was up 3.1% on a year-over-year basis. On average, research analysts anticipate that Bath & Body Works, Inc. will post 3.26 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 7th. Investors of record on Friday, February 21st will be given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 2.08%. The ex-dividend date is Friday, February 21st. Bath & Body Works’s payout ratio is 19.51%.

Wall Street Analyst Weigh In

Several analysts have issued reports on BBWI shares. Morgan Stanley lowered their target price on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a research note on Thursday, November 21st. JPMorgan Chase & Co. upgraded Bath & Body Works from a “neutral” rating to an “overweight” rating and boosted their target price for the company from $41.00 to $47.00 in a research note on Tuesday. TD Cowen boosted their target price on Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. Barclays boosted their target price on Bath & Body Works from $28.00 to $34.00 and gave the company an “underweight” rating in a research note on Tuesday, November 26th. Finally, Telsey Advisory Group restated an “outperform” rating and issued a $43.00 target price on shares of Bath & Body Works in a research note on Thursday. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $43.63.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.